ChemicalBook
Chinese Japanese Germany Korea

AMPRENAVIR

AMPRENAVIR
AMPRENAVIR structure
CAS No.
161814-49-9
Chemical Name:
AMPRENAVIR
Synonyms
PROZEI;141W94;VX 478;KVX-478;AGENERASE;AMPRENAVIR;Angenerase;Amprenavir(KVX-478);AMprenavir(agenerase);141W94, KVX-478, Agenerase, Prozei,
CBNumber:
CB4186139
Molecular Formula:
C25H35N3O6S
Formula Weight:
505.63
MOL File:
161814-49-9.mol

AMPRENAVIR Properties

Melting point:
72-74°C
storage temp. 
-20°C Freezer
solubility 
DMSO: soluble20mg/mL, clear
form 
powder
color 
white to beige
optical activity
[α]/D +8 to +12°, c = 0.5 in methanol
InChIKey
YMARZQAQMVYCKC-OEMFJLHTSA-N

SAFETY

RIDADR  3077
WGK Germany  3
HS Code  29350090

AMPRENAVIR price More Price(6)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Sigma-Aldrich SML0685 Amprenavir ≥98% (HPLC) 161814-49-9 5mg $93.2 2018-11-13 Buy
Sigma-Aldrich SML0685 Amprenavir ≥98% (HPLC) 161814-49-9 25mg $375 2018-11-13 Buy
Cayman Chemical 15369 Amprenavir ≥95% 161814-49-9 25mg $319 2018-11-13 Buy
Cayman Chemical 15369 Amprenavir ≥95% 161814-49-9 5mg $75 2018-11-13 Buy
Cayman Chemical 15369 Amprenavir ≥95% 161814-49-9 50mg $600 2018-11-13 Buy

AMPRENAVIR Chemical Properties,Uses,Production

Description

Amprenavir was launched as Agenerase in the US for the treatment of AIDS patients in combination with approved agent antiretroviral nucleoside analogs. It is the fifth non-peptidic inhibitor of HIV-1 protease to be marketed in this indication after the last approved Neflinavir. Amprenavir, designed via a structure-based process, is the smallest molecule in the 《navir》 class and exhibits a reduced peptidic character. An improved process for preparation comprising four steps from a (1S, 2R)-2-hydroxy-3-aminopropylcarbamate has been developed. Amprenavir is a potent inhibitor of HIV-1 aspartyl protease (Ki = 0.6nM), an enzyme required by the virus to cleave pro-form polyproteins to structural proteins during the last stage in the replication process. The compound displays good oral bioavailability in humans and penetrates the CNS, which is an important advantage in long-term treatment. Its plasma half-life is approximately 10h. Treatment with Amprenavir in combination with nucleoside analog reverse transcriptase inhibitors considerably decreases viral load and restores CD4+ T-cell counts in patients with HIV infection.

Chemical Properties

Off-White to Pale Yellow

Originator

Vertex Pharm (US)

Uses

A selective HIV protease inhibitor. An analogue of Ritonavir

Uses

Protease inhibitor, anti-HIV agent

brand name

Agenerase (GlaxoSmithKline).

Acquired resistance

Mutations at position 50, 76 and 84 of the protease enzyme gene are associated with significantly reduced susceptibility.

Pharmaceutical Applications

A synthetic compound formulated as the calcium salt of the oral prodrug fosamprenavir.

Pharmacokinetics

Oral absorption: Not known/available
Cmax 700 mg + ritonavir 100 mg:c. 6.08 mg/L
twice daily
Cmin 700 mg + ritonavir 100 mg:c. 2.12 mg/L
twice daily
Plasma half-life: c. 7.7 h
Volume of distribution: c. 430 L
Plasma protein binding: c. 90%
Absorption
Fosamprenavir is rapidly and almost completely hydrolyzed to amprenavir and inorganic phosphate by cellular phosphatases in the gut epithelium as it is absorbed. Absolute bioavailability has not been established. It can be taken without regard to food.
Distribution
It penetrates moderately well into the CNS. The semen:plasma ratio is negligible. It is not known if it is distributed into breast milk.
Metabolism and excretion
It is extensively metabolized by the cytochrome P450 (CYP) 3A4 enzyme system. Two major metabolites have been identified that appear to result from the oxidation of the tetrahydrofuran and aniline moieties. Around 14% of a dose is eliminated in the urine and 75% in feces, <3% as unchanged drug. Metabolites account for >90% of administered drug found in fecal samples. It should be used with caution and at reduced doses in adults with mild or moderate hepatic impairment; it is contraindicated in patients with severe hepatic impairment.

Clinical Use

Treatment of HIV infection (in combination with other antiretroviral drugs)

Side effects

The most common adverse events in patients receiving boosted fosamprenavir were diarrhea, nausea, headache, fatigue, vomiting and rash. Ritonavir-boosted fosamprenavir is associated with a dyslipidemia profile characteristic of those treated with other protease inhibitors boosted with 200 mg of ritonavir.

AMPRENAVIR Preparation Products And Raw materials

Raw materials

Preparation Products


AMPRENAVIR Suppliers

Global( 112)Suppliers
Supplier Tel Fax Email Country ProdList Advantage
Alpha Biopharmaceuticals Co., Ltd
0086-411-39042497
0086-411-39042693 sales@alphabiopharm.com China 1954 58
Capot Chemical Co.,Ltd.
+86 (0)571-855 867 18
+86 (0)571-858 647 95 sales@capotchem.com China 19918 60
Biochempartner
0086-13720134139
candy@biochempartner.com CHINA 956 58
Chemwill Asia Co.,Ltd.
86-21-51086038
86-21-51861608 chemwill_asia@126.com;sales@chemwill.com;chemwill@hotmail.com;chemwill@gmail.com CHINA 24001 58
Hubei Jusheng Technology Co.,Ltd.
86-188-71490254
peter@hubeijusheng.com CHINA 20095 58
Shanghai Hanxiang Biotechnology Co. Ltd. 15971444841
amber@biochempartner.net China 4991 58
Chengdu Lanhao Biotechnology Co., Ltd. 15397625210
1813129729@qq.com China 18 58
Shanghai Boyle Chemical Co., Ltd.
86-21-57758967 sales@boylechem.com China 2927 55
J & K SCIENTIFIC LTD. 400-666-7788 +86-10-82848833
+86-10-82849933 jkinfo@jkchemical.com;market6@jkchemical.com China 96815 76
3B Pharmachem (Wuhan) International Co.,Ltd. 86-21-50328103 * 801、802、803、804 Mobile:18930552037
86-21-50328109 3bsc@sina.com China 15884 69

161814-49-9(AMPRENAVIR)Related Search:


  • [(3S)-Oxolan-3-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamate
  • N-[(1S,2R)-3-[[(4-AMinophenyl)sulfonyl](2-Methylpropyl)aMino]-2-hydroxy-1-(phenylMethyl)propyl]carbaMic Acid (3S)-Tetrahydro-3-furanyl Ester
  • AMprenavir(agenerase)
  • Amprenavir(KVX-478)
  • KVX-478
  • AGENERASE
  • AMPRENAVIR
  • 141W94
  • PROZEI
  • 141W94, KVX-478, Agenerase, Prozei,
  • Carbamic acid, (1S,2R)-3-(4-aminophenyl)sulfonyl(2-methylpropyl)amino-2-hydroxy-1-(phenylmethyl)propyl-, (3S)-tetrahydro-3-furanyl ester
  • Angenerase
  • Carbamic acid, [3-[[(4-aminophenyl)sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]-, tetrahydro-3-furanyl ester, [3S-[3R*(1R*,2S*)]]-
  • VX 478
  • 161814-49-9
  • C25H35N3O6S
  • Anti-viral Compounds
  • Anti-virals
  • Inhibitors
  • Intermediates & Fine Chemicals
  • Non-nucleoside Reverse Transcriptase
  • Pharmaceuticals
  • API
  • Inhibitor
  • peptides
Copyright 2017 © ChemicalBook. All rights reserved